- Repurposing calcilytics for inflammatory lung diseases
P Yarova, M Schepelmann, E Kidd, W Ford, K Broadley, J Ward, C Corrigan, P Kemp, D Riccardi
- RGL1 as a novel target for the anti-cancer effects of celecoxib
S Mazi, G Galaris, H Gashaw, J Mitchell, N Kirkby
- Role of pannexin channels in mediating endothelium dependent vasorelaxation in PSA
A Habib, W Dunn, V Ralevic
- Role of peroxisome proliferator-activated receptors-alpha (PPARα) and the transient receptor potential vanilloid receptor (TRPV1) in mediating the anti-nociceptive effects of palmitoylethanolamine in rat
M Alsalem, A Altarifi, A Imraish
- Safety screenings for cytokine storm-inducing biologics using cryopreserved BOECs and PBMCs
K Tan, D Reed, A Zetterqvist, Z Nikolakopoulou, Q Toe, N Kirkby, J Mitchell
- Screening of multiple sclerosis using human tissue chip model with vasicine
A Balasundaram, D C David
- Sex and agonist-specific mechanisms of cannabinoid tolerance
A Redmond, E Ferguson, A Kline, C Nealon, D Morgan
- Simvastatin prevents KATP channel-mediated vasodilation in pulmonary hypertension
M Absi, M Al-Chawishly, G Hart, A Gurney
- Simvastatin reduces interleukin-1 beta secretion from peripheral blood mononuclear cells when treated wiht cholesterol crystals
M Lucitt, N Gangadharan, P Kavanagh, P Walsh, L Hemeryck, J Kieran, M Barry
- Small-molecule biased formyl peptide receptor agonist compound 17b protects against myocardial ischemia-reperfusion injury in mice
C X Qin, L May, R Li, N Cao, S Rosli, M Deo, A Alexander, D Horlock, J Bourke, Y Yang, A Stewart, D Kaye, X-J Du, P Sexton, A Christopoulos, X-M Gao, R Ritchie